Ginkgo Bioworks

Yahoo Finance • 2 months ago

Ginkgo Bioworks Holdings Inc (NYSE:DNA) Fits the Minervini Trend Template with Strong Technicals and High-Growth Momentum

Ginkgo Bioworks Holdings Inc (NYSE:DNA [https://www.chartmill.com/stock/quote/DNA]) has become a possible choice for investors using the Mark Minervini Trend Template and high-growth momentum strategies. The Minervini method blends strict... Full story

Yahoo Finance • 3 months ago

Ginkgo Bioworks launches cost-effective ADME profiling service

BOSTON - Ginkgo Bioworks (NYSE:DNA), a biotechnology company with a robust balance sheet showing a current ratio of 4.88x, announced on Thursday the introduction of a new high-throughput ADME profiling service aimed at accelerating small m... Full story

Yahoo Finance • 6 months ago

Is Ginkgo Bioworks Holdings, Inc. (DNA) the Best Gene-Editing Stock to Buy?

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) stands against other best gene-editing stocks to buy. Gene editing is an ad... Full story

Yahoo Finance • last year

This 1 AI Stock Could Revolutionize Biotech and Pharma

Ginkgo Bioworks(NYSE: DNA) is a biotech that's going big on artificial intelligence (AI). Between its need to perform core workflows with high efficiency, and its generation of tons of biological and manufacturing data that demand analysis... Full story

Yahoo Finance • last year

Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE

Ginkgo's Class A Common Stock continues to trade on the NYSE BOSTON, May 13, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and biose... Full story

Yahoo Finance • 2 years ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought This Week

There never seems to be a bad time for Cathie Wood to reshape her portfolios. The founder, CEO, and main stock-picker for the Ark Invest family of exchange-traded funds has been busy adding to some of her positions this week. She has also... Full story

Yahoo Finance • 2 years ago

4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024

Cathie Wood crushed it in 2023. Her flagship Ark Innovation ETF(NYSEMKT: ARKK) soared nearly 67%. The Ark Next Generation Internet ETF(NYSEMKT: ARKW) performed even better with an impressive 97% gain. If analysts are right, Wood could hav... Full story

Yahoo Finance • 2 years ago

2 Cathie Wood Stocks That Might Be Smart Buys Right Now

innovation Investors have shown a lot of interest in thematic exchange-traded funds (ETFs) since 2019. These funds focus on specific themes or sectors expected to grow rapidly in the future. One of the prominent players in this space is A... Full story

Yahoo Finance • 2 years ago

Ark Invest Stock Portfolio: 16 Biggest Positions

In this article, we discuss the 16 biggest positions in the ARK Invest portfolio. If you want to read about some more stocks in the ARK Invest portfolio, go directly to Ark Invest Stock Portfolio: 5 Biggest Positions. Catherine D. Wood, a... Full story

Yahoo Finance • 2 years ago

12 Best Genomics Stocks To Buy Now

In this piece, we will take a look at the 12 best genomics stocks to buy now. If you want to skip our introduction to the genomics industry and all the latest trends, then take a look at 5 Best Genomics Stocks To Buy Now. If there's one t... Full story

Yahoo Finance • 2 years ago

XWELL, Inc. Reports Third Quarter 2023 Results

Airport Spas Deliver Strong 39% Year-Over-Year Q3 Revenue Growth Naples Wax Center Acquisition Accelerates Future Off-Airport Growth Opportunities Further Airport Spa Expansion Internationally NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) --... Full story

Yahoo Finance • 2 years ago

Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens

NEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and XWELL, Inc. (Nasdaq: XWEL) today announced they are expanding their work with the U... Full story

Yahoo Finance • 2 years ago

11 Best Medical  Stocks Under $10

In this piece, we will take a look at the eleven best medical stocks under $10. If you want to skip our analysis of the medical industry and recent trends, head on over to 5 Best Medical  Stocks Under $10. The medical industry is one of t... Full story

Yahoo Finance • 2 years ago

XWELL, Inc. Reports First Quarter 2023 Results

NEW YORK, May 15, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in health and wellness solutions for people on the go, today reported results for the first quarter ended March 31, 2023. Bus... Full story

Yahoo Finance • 3 years ago

Solvay announces strategic collaboration with Ginkgo Bioworks and expands its R&I footprint in the United States

Press release Solvay announces strategic collaboration with Ginkgo Bioworks and expands its R&I footprint in the United States The investment will accelerate the development of new sustainable biopolymers, strengthening Solvay’s position... Full story

Yahoo Finance • 3 years ago

SHAREHOLDER ALERT: Morris Kandinov Investigating PRVB, MAXR, DNA, and FOX; Shareholders are Encouraged to Contact the Firm

SAN DIEGO, March 29, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating Provention Bio, Inc., Maxar Technologies Inc., Ginkgo Bioworks Holdings, Inc., and Fox Corporation. If you are a current owner of shares, co... Full story

Yahoo Finance • 3 years ago

Bragar Eagel & Squire is Investigating Certain Officers and Directors of C3.ai, Ginkgo Bioworks, and Polished on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, March 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors C3.ai, Inc. (NYSE: AI), Ginkgo Bioworks Holdings, Inc. (NYSE:... Full story

Yahoo Finance • 3 years ago

GINKGO BIOWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) on behalf of long-term st... Full story

Yahoo Finance • 3 years ago

SHAREHOLDER ALERT: Morris Kandinov Investigating DNA, APA, LDI and BFLY; Shareholders are Encouraged to Contact the Firm

SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating Ginkgo Bioworks Holdings, Inc., APA Corporation, loanDepot, Inc., and Butterfly Network, Inc. If you are a current owner of shares, contact l... Full story

Yahoo Finance • 3 years ago

NYSE: DNA Investor Notice: Update in Lawsuit for Investor who lost money with shares of Ginkgo Bioworks Holdings, Inc. announced by the Shareholders Foundation

SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA). Investors, who purchased Gi... Full story